Navamedic ASA - Asset Resilience Ratio

Latest as of December 2025: 11.25%

Navamedic ASA (NAVA) has an Asset Resilience Ratio of 11.25% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Navamedic ASA carry for a breakdown of total debt and financial obligations.

Liquid Assets

Nkr83.45 Million
≈ $8.78 Million USD Cash + Short-term Investments

Total Assets

Nkr741.75 Million
≈ $78.05 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2008–2025)

This chart shows how Navamedic ASA's Asset Resilience Ratio has changed over time. See NAVA total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Navamedic ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Navamedic ASA (NAVA) total market value.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Nkr74.16 Million 10.0%
Short-term Investments Nkr9.30 Million 1.25%
Total Liquid Assets Nkr83.45 Million 11.25%

Asset Resilience Insights

  • Moderate Liquidity: Navamedic ASA has 11.25% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Navamedic ASA Industry Peers by Asset Resilience Ratio

Compare Navamedic ASA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
Medical Distribution 5.56%

Annual Asset Resilience Ratio for Navamedic ASA (2008–2025)

The table below shows the annual Asset Resilience Ratio data for Navamedic ASA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 11.25% Nkr83.45 Million
≈ $8.78 Million
Nkr741.75 Million
≈ $78.05 Million
+0.61pp
2024-12-31 10.64% Nkr52.27 Million
≈ $5.50 Million
Nkr491.24 Million
≈ $51.69 Million
+3.34pp
2023-12-31 7.30% Nkr38.29 Million
≈ $4.03 Million
Nkr524.30 Million
≈ $55.17 Million
-9.78pp
2022-12-31 17.08% Nkr65.39 Million
≈ $6.88 Million
Nkr382.77 Million
≈ $40.28 Million
+1.15pp
2021-12-31 15.94% Nkr52.62 Million
≈ $5.54 Million
Nkr330.18 Million
≈ $34.74 Million
+14.11pp
2020-12-31 1.83% Nkr4.76 Million
≈ $501.20K
Nkr260.04 Million
≈ $27.36 Million
+9.38pp
2019-12-31 -7.55% Nkr-14.13 Million
≈ $-1.49 Million
Nkr187.06 Million
≈ $19.68 Million
-12.70pp
2018-12-31 5.14% Nkr11.05 Million
≈ $1.16 Million
Nkr214.73 Million
≈ $22.60 Million
-7.09pp
2017-12-31 12.23% Nkr30.25 Million
≈ $3.18 Million
Nkr247.27 Million
≈ $26.02 Million
+2.92pp
2016-12-31 9.32% Nkr26.80 Million
≈ $2.82 Million
Nkr287.67 Million
≈ $30.27 Million
-54.54pp
2008-12-31 63.86% Nkr101.95 Million
≈ $10.73 Million
Nkr159.65 Million
≈ $16.80 Million
--
pp = percentage points

About Navamedic ASA

OL:NAVA Norway Medical Distribution
Market Cap
$47.82 Million
Nkr454.45 Million NOK
Market Cap Rank
#22062 Global
#204 in Norway
Share Price
Nkr18.95
Change (1 day)
-0.26%
52-Week Range
Nkr18.95 - Nkr26.40
All Time High
Nkr42.60
About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more